Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of AZLI in Children with CF and Chronic PA
NCT01404234Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Dec 2011
- Primary completion
- Apr 2013
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of aztreonam in cystic fibrosis (CF), Pseudomonas aeruginosa infection, sponsored by Gilead Sciences. Started Dec 2011; status: completed.
02
Drugs
aztreonam
03
Conditions
cystic fibrosis (CF)Pseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT01404234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01404234.